Diffusion Tensor Analysis of Pediatric Multiple Sclerosis and Clinically Isolated Syndromes

References

1. 1.↵
   1. Chitnis T,
   2. Glanz B,
   3. Jaffin S,
   4. et al

   . Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009;15:627–31

   Abstract/FREE Full Text
2. 2.↵
   1. Boiko A,
   2. Vorobeychik G,
   3. Paty D,
   4. et al

   . Early onset multiple sclerosis: a longitudinal study. Neurology 2002;59:1006–10

   Abstract/FREE Full Text
3. 3.↵
   1. Ghezzi A,
   2. Deplano V,
   3. Faroni J,
   4. et al

   . Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997;3:43–46

   Abstract/FREE Full Text
4. 4.↵
   1. Renoux C,
   2. Vukusic S,
   3. Mikaeloff Y,
   4. et al

   . Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603–13

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Gorman MP,
   2. Healy BC,
   3. Polgar-Turcsanyi M,
   4. et al

   . Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009;66:54–59

   CrossRefPubMedWeb of Science
6. 6.↵
   1. MacAllister WS,
   2. Belman AL,
   3. Milazzo M,
   4. et al

   . Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005;64:1422–25

   Abstract/FREE Full Text
7. 7.↵
   1. Amato MP,
   2. Goretti B,
   3. Ghezzi A,
   4. et al

   . Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008;70:1891–97

   Abstract/FREE Full Text
8. 8.↵
   1. Hahn CD,
   2. Shroff MM,
   3. Blaser SI,
   4. et al

   . MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004;62:806–08

   Abstract/FREE Full Text
9. 9.↵
   1. Vishwas M,
   2. Chitnis T,
   3. Pienaar R,
   4. et al

   . Tract-based analysis of callosal, projection and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol 2010;31:121–28

   Abstract/FREE Full Text
10. 10.↵
    1. Mikaeloff Y,
    2. Suissa S,
    3. Vallee L,
    4. et al

    . First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246–52

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Mikaeloff Y,
    2. Adamsbaum C,
    3. Husson B,
    4. et al

    . MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942–47

    Abstract/FREE Full Text
12. 12.↵
    1. Neuteboom RF,
    2. Boon M,
    3. Catsman Berrevoets CE,
    4. et al

    . Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008;71:967–73

    Abstract/FREE Full Text
13. 13.↵
    1. Krupp LB,
    2. Banwell B,
    3. Tenembaum S

    . Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68:S7–12

    Abstract/FREE Full Text
14. 14.↵
    1. Mori S,
    2. van Zijl PC

    . Fiber tracking: principles and strategies—a technical review. NMR Biomed 2002;15:468–80

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Wakana S,
    2. Jiang H,
    3. Nagae-Poetscher LM,
    4. et al

    . Fiber tract-based atlas of human white matter anatomy. Radiology 2004;230:77–87

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Catani M,
    2. Howard RJ,
    3. Pajevic S,
    4. et al

    . Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage 2002;17:77–94

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Catani M,
    2. Thiebaut de Schotten M

    . A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 2008;44:1105–32

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Bester M,
    2. Heesen C,
    3. Schippling S,
    4. et al

    . Early anisotropy changes in the corpus callosum of patients with optic neuritis. Neuroradiology 2008;50:549–57

    CrossRefPubMed
19. 19.↵
    1. Yu CS,
    2. Lin FC,
    3. Liu Y,
    4. et al

    . Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008;68:328–34

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Caramia F,
    2. Pantano P,
    3. Di Legge S,
    4. et al

    . A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging 2002;20:383–88

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Werring DJ,
    2. Clark CA,
    3. Barker GJ,
    4. et al

    . Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–32

    Abstract/FREE Full Text
22. 22.↵
    1. Cercignani M,
    2. Inglese M,
    3. Pagani E,
    4. et al

    . Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952–58

    Abstract/FREE Full Text
23. 23.↵
    1. Hasan KM,
    2. Gupta RK,
    3. Santos RM,
    4. et al

    . Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 2005;21:735–43

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Inglese M,
    2. Salvi F,
    3. Iannucci G,
    4. et al

    . Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2002;23:267–72

    Abstract/FREE Full Text
25. 25.↵
    1. Vrenken H,
    2. Seewann A,
    3. Knol DL,
    4. et al

    . Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 2010;31:541–48

    Abstract/FREE Full Text
26. 26.↵
    1. Rocca MA,
    2. Absinta M,
    3. Moiola L,
    4. et al

    . Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology 2010;254:541–50

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Chitnis T,
    2. Pirko I

    . Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS. Neurology 2009;72:952–53

    FREE Full Text
28. 28.↵
    1. Kappos L,
    2. Freedman MS,
    3. Polman CH,
    4. et al

    . Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007;370:389–97

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Kinkel RP,
    2. Kollman C,
    3. O'Connor P,
    4. et al

    . IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006;66:678–84

    Abstract/FREE Full Text